PRODUCTION OF INTERFERON BY HUMAN-TUMOR CELL-LINES

被引:20
|
作者
JAMESON, P
GROSSBERG, SE
机构
[1] Department of Microbiology, The Medical College of Wisconsin, Milwaukee, Wisconsin
关键词
D O I
10.1007/BF01317553
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Fourteen continuous human cell lines, including nine derived from tumors and five from non-neoplastic tissues, produced interferon in response to induction with bluetongue virus (BTV), Newcastle disease virus (NDV), and poly(I) · poly(C) complexed with DEAE-dextran. The seven best interferon-producing cell lines (one from a melanoma, five derived from carcinomas, and one SV40-virus-transformed kidney cell line) responded to at least one of the viral inducers with yields of interferon over 1000 units/ml. Because the HT-1376 bladder carcinoma cell line produced high yields of interferon in this survey, and is easily propagated, the optimal conditions for interferon production were investigated, using BTV as the inducer. Interferon yields in 59 inductions over a period of about two years consistently fell within a 6-fold range, and had a geometric mean titer of about 2700 reference units (RU)/ml, representing the production of about 3 RU/103 cells. This yield is comparable to mean titers of 1 to 10 RU/103 cells obtained by others with human leukocytes, foreskin cell strains, or the Namalva lymphoblastoid cell line. UV-inactivated BTV at a multiplicity corresponding to 10 PFU/cell was as effective an inducer in the HT-1376 cell line as the fully infectious virus at a multiplicity of 1 PFU/cell. The interferon produced by the HT-1376 epithelial cell line has characteristics similar to the interferon induced by poly(I) · poly(C) in human diploid fibroblasts. These studies clearly demonstrate that many different types of tumor-derived cells have the capacity to produce interferon, and that some equal or surpass the efficiency of diploid cells. © 1979 Springer-Verlag.
引用
收藏
页码:209 / 219
页数:11
相关论文
共 50 条
  • [1] ACTIVITY OF GAMMA-INTERFERON AGAINST HUMAN-TUMOR CELL-LINES
    VASTOLA, KA
    DIVIAK, LF
    OMALLEY, JA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 164 - 164
  • [2] PRODUCTION OF TUMOR ANGIOGENESIS FACTOR (TAF) BY HUMAN-TUMOR CELL-LINES
    TOLBERT, WR
    KUO, MJ
    FEDER, J
    IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1981, 17 (03): : 259 - 259
  • [3] PRODUCTION OF ERYTHROID POTENTIATING FACTOR (EPF) BY HUMAN-TUMOR CELL-LINES
    ASCENSAO, JL
    VESELA, R
    ZANJANI, ED
    CLINICAL RESEARCH, 1981, 29 (02): : A328 - A328
  • [4] RESISTANCE OF HUMAN-TUMOR CELL-LINES TO ANTIFOLATES
    DIDDENS, H
    NIETHAMMER, D
    JACKSON, RC
    CANCER TREATMENT REVIEWS, 1984, 11 : 37 - 41
  • [5] EFFECT OF HUMAN RECOMBINANT INTERFERON (IFN) IN COMBINATION WITH DEOXYCOFORMYCIN (DCF) ON HUMAN-TUMOR CELL-LINES
    DENZ, H
    NACHBAUR, D
    LECHLEITNER, M
    THALER, J
    HUBER, H
    JOURNAL OF INTERFERON RESEARCH, 1987, 7 (06): : 740 - 740
  • [6] INDEPENDENT SENSITIVITY OF HUMAN-TUMOR CELL-LINES TO INTERFERON AND DOUBLE-STRANDED-RNA
    HUBBELL, HR
    LIU, RS
    MAXWELL, BL
    CANCER RESEARCH, 1984, 44 (08) : 3252 - 3257
  • [7] COMPONENTS OF THE FIBRINOLYTIC SYSTEM IN HUMAN-TUMOR CELL-LINES
    KWAAN, HC
    RADOSEVICH, JA
    LASTRE, C
    KABET, W
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 142 - 142
  • [8] LOSS OF HETEROZYGOSITY IN CULTURED HUMAN-TUMOR CELL-LINES
    DRACOPOLI, NC
    FOGH, J
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1983, 70 (01): : 83 - 87
  • [9] COMPARATIVE RADIOBIOLOGICAL PROPERTIES OF HUMAN-TUMOR CELL-LINES
    STEEL, GG
    DEACON, JM
    DUCHESNE, GM
    KELLAND, LR
    PEACOCK, JH
    BRITISH JOURNAL OF RADIOLOGY, 1987, 60 (709) : 104 - 104
  • [10] HUMAN-TUMOR CELL-LINES AND THE SCREENING OF ANTICANCER AGENTS
    MASTERS, JRW
    HEPBURN, PJ
    WALKER, MC
    PARRIS, CN
    JENKINS, WEA
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1986, 42 : 50 - 50